Skip to main content
OpenTrials
Completed

NCT Number: NCT03945123

Effects of Red Ginseng on Liver Function

Korea Red Ginseng (KRG) has effect on liver function

Completed

Looking for future studies?

Notify Me

Key information

Age range

37 year–63 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ChuncheonSHH

Chuncheon, Gangwon-do, South Korea

About this study

Korea Red Ginseng (KRG) has been known as a natural product with anti-inflammatory effect in liver disease. Gut microbiota plays an important roles in the pathophysiology of nonalcoholic statohepatitis (NASH). We evaluated the effect of KRG on the pathophysiology of NASH

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • AST or ALT level > 50 IU/L

Exclusion criteria

  • Viral hepatitis
  • Alcoholic hepatitis
  • Autoimmune hepatitis
  • Pancreatitis
  • Hemochromatosis
  • Wilson's disease
  • Drug induced liver injury
  • Cancer

Treatment and study plan

Red ginseng

Dietary Supplement

Red ginseng tablet 120g

Other names: Red ginseng tablet

Primary outcomes

  1. Liver enzyme

    Time frame: 1year

    Decrease liver enzyme level

Sponsors and collaborators

Lead sponsor

Chuncheon Sacred Heart Hospital

Other

Registry information

Official study title

Effect of Korea Red Ginseng on Non-alcoholic Fatty Liver Disease

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 10, 2019
Registry last updated
May 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.